Welcome!

News Feed Item

HASCO Medical Reports Record First Quarter 2014 Results

Q1 2014 Total Net Revenues up 38% to Record $20.7 Million, Driving Net Income of $194,000

ADDISON, TX -- (Marketwired) -- 08/20/14 -- HASCO Medical, Inc. (OTCQB: HASC), a leading provider of handicap-accessible vans, parts and service, reported results for the first quarter ended March 31, 2014.

Q1 2014 Financial and Operational Highlights

  • Revenues up 38% to a record $20.7 million, marking five consecutive quarters of record revenue

  • Gross margin up 176 basis points to 25.4%

  • Net income of $194,000 vs. a net loss of $199,000 in same year-ago quarter

  • Delivered a record number of taxi orders totaling more than 100, which were sold primarily through the company's Ride-Away® Commercial Taxi location in NYC

Q1 2014 Financial Summary
Net revenues for the first quarter of 2014 totaled a record $20.7 million, up 38% from $15.0 million in the same year-ago quarter. The improvement was primarily due to the increase in private-pay business for van sales, as well as the contribution of Auto Mobility Sales that the company acquired last September. Service and other revenue totaled $3.9 million, up 36% from the same year-ago quarter.

Gross profit was a record $5.3 million or 25.4% of total net revenues, compared to $3.5 million or 23.7% of total net revenues in the same year-ago quarter. The increase is primarily due to the greater buying power and better utilization of capacity in service.

Net income totaled $194,000, as compared to net loss of $199,000 in the same year-ago quarter.

Management Commentary
"Our record first quarter results reflects strong sales of handicap accessible vehicles across all our East Coast dealerships," said Hal Compton, CEO of HASCO Medical. "We expect this sales momentum to be maintained with the help of two new dealerships we're planning to open in the Fall with the support of major brands like BraunAbility and VMI. As we look to the remainder of 2014, we expect our excellent customer service, high-quality products and custom solutions, and the strong tailwinds of a growing market to drive another record year."

2014 Outlook
HASCO Medical expects 2014 total net revenues to range between $75 million and $85 million, which represents an increase of 3% to 17%. The company also expects gross margin to range between 21% to 23%. The company also expects positive net income in 2014.

About HASCO Medical, Inc.
HASCO Medical is a leading provider of handicap accessible vans, parts, and service that dramatically improve the quality of living of its customers. The company operates 19 locations from Maine to Florida. The company's mobility brands include Ride-Away (www.Ride-Away.com), Auto Mobility Sales (www.automobilitysales.com), Mobility Freedom (www.MobilityFreedom.com) and Wheelchair Vans of America (www.wcvans.com). To learn more, go to www.hascomed.com.

Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.

                     Hasco Medical, Inc. & Subsidiaries
                        Consolidated Balance Sheets


                                                   March 31,   December 31,
                                                     2014          2013
                                                  (unaudited)
                                                 ------------  ------------
Assets
Current assets
  Cash                                           $    909,004  $    150,313
  Accounts receivable, net of allowance for
   doubtful accounts of $675,509 and $686,345,
   respectively                                     5,817,869     6,182,680
  Inventory, net                                   10,981,334    11,572,060
  Deferred tax asset, short term                      413,193       413,193
  Prepaid expenses and other current assets           654,411       504,819
                                                 ------------  ------------
Total current assets                               18,775,811    18,823,065
                                                 ------------  ------------

Property & equipment, net of accumulated
 depreciation of $1,387,930 and $1,164,634,
 respectively                                       2,164,217     2,141,212

Intangible assets, net of accumulated
 depreciation of $21,223 and $10,192,
 respectively                                       6,203,003     6,214,034
Deferred tax asset, long term                         149,204       149,204
Other non-current assets                              586,930       604,965
                                                 ------------  ------------
Total Assets                                     $ 27,879,165  $ 27,932,480
                                                 ============  ============

Liabilities and Stockholders' Equity
Current liabilities
  Accounts payable and accrued expenses          $  2,361,956  $  1,849,702
  Cash overdraft                                           --       175,572
  Customer deposits and deferred revenue              389,305       388,433
  Line of credit                                      928,810     2,303,143
  Note payable - floor plan                        12,655,167    12,174,639
  Obligation under capital leases                     321,712       366,658
  Current portion of notes payable                    382,966       376,685
  Current portion note payable, related party         335,312       353,008
  Other current liabilities                           875,085       493,923
                                                 ------------  ------------
Total current liabilities                          18,250,313    18,481,763
                                                 ------------  ------------

Obligation under capital leases, net of current
 portion                                              960,816       817,828
Notes payable, net of current portion               3,947,856     4,075,802
Notes payable to related party, net of current
 portion                                            1,838,927     1,947,214
                                                 ------------  ------------
Total liabilities                                  24,997,912    25,322,607
                                                 ------------  ------------

Stockholders' Equity
  Preferred stock, $0.001 par value, 3,000,000
   shares authorized, none issued and outstanding          --            --
  Common stock, $0.001 par value, 2,000,000,000
   shares authorized; and 996,938,389 and
   993,134,076 shares issued and outstanding,
   respectively                                       996,938       993,134
  Additional paid-in capital                        6,742,285     6,669,056
  Accumulated deficit                              (4,857,970)   (5,052,317)
                                                 ------------  ------------
Total stockholders' equity                          2,881,253     2,609,873
                                                 ------------  ------------

Total Liabilities and Stockholders' Equity       $ 27,879,165  $ 27,932,480
                                                 ============  ============



                     Hasco Medical, Inc. & Subsidiaries
                   Consolidated Statements of Operations
                                (unaudited)


                                                 For the Three Months Ended
                                                          March 31,
                                                 --------------------------
                                                     2014          2013
                                                 ------------  ------------

Product sales                                    $ 16,588,280  $ 11,855,547
Rental revenue                                        245,005       273,395
Service and other                                   3,852,318     2,826,546
                                                 ------------  ------------
  Total net revenues                               20,685,603    14,955,488
                                                 ------------  ------------

                                                 ------------  ------------
Cost of sales                                      15,425,817    11,415,351
                                                 ------------  ------------

Gross profit                                        5,259,786     3,540,137

Operating expenses:
  Selling and marketing                               953,798       917,500
  General and administrative                        3,415,207     2,486,904
  Amortization and depreciation                       234,327       319,974
                                                 ------------  ------------
    Total operating expenses                        4,603,332     3,724,378
                                                 ------------  ------------

Income (loss) from operations                         656,454      (184,241)

Other income (expense)
  Other income                                         20,989        49,192
  Interest expense                                   (302,838)     (193,577)
                                                 ------------  ------------
    Total other income (expense)                     (281,849)     (144,385)
                                                 ------------  ------------

Income (loss) from continuing operations before
 income taxes                                         374,605      (328,626)

Provision for (benefit from) income taxes             170,218      (261,000)

                                                 ------------  ------------
Income (loss) from continuing operations              204,387       (67,626)
(Loss) from discontinued operations, net of
 income tax                                           (10,040)     (131,086)
                                                 ------------  ------------
Net income (loss)                                $    194,347  $   (198,712)
                                                 ============  ============

Earnings per share:
  Basic and dilutive-Continuing Operations       $       0.00          0.00
                                                 ============  ============
  Basic and dilutive-Discontinued Operations     $       0.00  $       0.00
                                                 ============  ============

Weighted average shares outstanding:
  Basic and dilutive                              994,619,535   988,069,704
                                                 ============  ============

Company Contact:
HASCO Medical, Inc.
214-302-0930
Email Contact

Investor Relations Contacts:
Liolios Group, Inc.
Ron Both, Senior Managing Director
949-574-3860
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that Silicon India has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Published in Silicon Valley, Silicon India magazine is the premiere platform for CIOs to discuss their innovative enterprise solutions and allows IT vendors to learn about new solutions that can help grow their business.
You want to start your DevOps journey but where do you begin? Do you say DevOps loudly 5 times while looking in the mirror and it suddenly appears? Do you hire someone? Do you upskill your existing team? Here are some tips to help support your DevOps transformation. Conor Delanbanque has been involved with building & scaling teams in the DevOps space globally. He is the Head of DevOps Practice at MThree Consulting, a global technology consultancy. Conor founded the Future of DevOps Thought Leade...
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
Founded in 2000, Chetu Inc. is a global provider of customized software development solutions and IT staff augmentation services for software technology providers. By providing clients with unparalleled niche technology expertise and industry experience, Chetu has become the premiere long-term, back-end software development partner for start-ups, SMBs, and Fortune 500 companies. Chetu is headquartered in Plantation, Florida, with thirteen offices throughout the U.S. and abroad.
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
DXWorldEXPO LLC announced today that "IoT Now" was named media sponsor of CloudEXPO | DXWorldEXPO 2018 New York, which will take place on November 11-13, 2018 in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
The technologies behind big data and cloud computing are converging quickly, offering businesses new capabilities for fast, easy, wide-ranging access to data. However, to capitalize on the cost-efficiencies and time-to-value opportunities of analytics in the cloud, big data and cloud technologies must be integrated and managed properly. Pythian's Director of Big Data and Data Science, Danil Zburivsky will explore: The main technology components and best practices being deployed to take advantage...
Andi Mann, Chief Technology Advocate at Splunk, is an accomplished digital business executive with extensive global expertise as a strategist, technologist, innovator, marketer, and communicator. For over 30 years across five continents, he has built success with Fortune 500 corporations, vendors, governments, and as a leading research analyst and consultant.
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
Most DevOps journeys involve several phases of maturity. Research shows that the inflection point where organizations begin to see maximum value is when they implement tight integration deploying their code to their infrastructure. Success at this level is the last barrier to at-will deployment. Storage, for instance, is more capable than where we read and write data. In his session at @DevOpsSummit at 20th Cloud Expo, Josh Atwell, a Developer Advocate for NetApp, will discuss the role and value...
DXWorldEXPO LLC announced today that ICOHOLDER named "Media Sponsor" of Miami Blockchain Event by FinTechEXPO. ICOHOLDER gives detailed information and help the community to invest in the trusty projects. Miami Blockchain Event by FinTechEXPO has opened its Call for Papers. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Miami Blockchain Event by FinTechEXPOalso offers sp...
Today, we have more data to manage than ever. We also have better algorithms that help us access our data faster. Cloud is the driving force behind many of the data warehouse advancements we have enjoyed in recent years. But what are the best practices for storing data in the cloud for machine learning and data science applications?
DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term.